Terumo Cardiovascular Group

manufactures and commercializes medical devices for cardiac and vascular surgery...
Read more
Terumo Cardiovascular Group CEO: Robert DeRyke

CEO

Robert DeRyke

CEO Approval Rating

70/100

Est. Annual Revenue
$500M-1.0B
Agree?
Est. Employees
500-1.0K
Agree?

News

Sep 16, 2022
Medical Product Outsourcing
Terumo Cardiovascular Group: Terumo Cardiovascular Opens New Facility in Costa Rica
Sep 10, 2021
DBusiness Magazine
Terumo Cardiovascular Group: Ann Arbor's Terumo Cardiovascular Partners with Boston Firm on Cardiac Monitoring
Sep 09, 2021
MarketScreener
Terumo Cardiovascular Group: Etiometry : and Terumo Cardiovascular Announce Partnership to Deliver Enhanced Monitoring Insights for Adult Cardiac Surgery Patients
Aug 25, 2020
NS Medical Devices
Terumo Cardiovascular Group: Terumo Cardiovascular and CytoSorbents collaborate to commercialize CytoSorb in ten U.S. hotspot states under emergency use authorization for COVID-19
Aug 25, 2020
DBusiness Magazine
Terumo Cardiovascular Group: Ann Arbor Firm Helps Release Critical Product to Oxygenate Blood in COVID-19 Patients
Dec 19, 2019
BioPortfolio
Terumo Cardiovascular Group: Terumo Cardiovascular Systems Corp Strategic SWOT Analysis Review Report Updated 18042019 Prices from USD $106
Nov 23, 2019
BioPortfolio
Terumo Cardiovascular Group: Terumo Cardiovascular Systems Corp Strategic SWOT Analysis Review Report Updated 18042019 Prices from USD $110
Aug 17, 2019
BioPortfolio
Terumo Cardiovascular Group: Terumo Cardiovascular Systems Corp Strategic SWOT Analysis Review Published by Global Data Prices from USD $125
May 08, 2019
BioPortfolio
Terumo Cardiovascular Group: Terumo Cardiovascular Talis Clinical introduce ACGPerfusion and ACGRemoteView systems
Feb 20, 2019
BioPortfolio
Terumo Cardiovascular Group: Terumo Cardiovascular Group Hemostasis introduce BoneSeal bone hemostat

Terumo Cardiovascular Group Competitors

1Abiomed
2Conformis
3SynCardia
4Avinger
5Mitralign
6Medtronic
7MAQUET
8Boston Scientific
9Abbott

Trending Companies